News

Press Release

COBO Technologies and BioXpedia Join Forces to Develop CRISPR QC Platform for Future Gene Therapies

Press Release

COBO Technologies has been given the International Life Science Award from Global Health & Pharma (GHP)

Publication

Applications of CRISPR-Cas Systems Beyond Genome Editing

News

Join Keyi Geng and Eric Paul Bennett in this two-part webinar discussing the nature of these unexpected gene editing outcomes and ways to detect and characterise both the expected and unexpected editing outcomes.

CRISPR Medicine News

This year CRISPR broke new ground in medicine. We saw the first CRISPR gene editing directly in the body, CRISPR took huge wins in clinical trials and not least was awarded the Nobel Prize in Chemistry.

Product Launch

ProfileIt has been upgraded to its version 2.0 which includes InDel analysis for the DNA Analyzer ABI3730xl.

Publication

Read more about the key features of SWATH Acquisition for CRISPR proteome profiling.

Clinical Trials

New CRISPR gene editing clinical studies are rapidly emerging, now with more than 45 ongoing clinical trials including CRISPR, ZFNs, TALENs or MegaNucleases. Check the latest updates from CRISPR Medicine News.

Webinar

Cobo Technologies PIPPR® platform has been specifically designed to understand, at the proteome level, the changes caused by CRISPR genetic editing of cell lines, whether of animal or plant origin.

News

The CRISPR Medicine News site has launched the worlds first overview of ongoing clinical trials within the genome editing field. This overview will include any trials from Asia, US and Europe, where genome editing tools like CRISPR, ZFNs, TALENs and MegaNucleases have been used.

Article

Take a look at how gene drives are being studied using CRISPR/Cas9 technology on the African malarian vector Anopheles gambiae.

PIPPR Service

The RAW 264.7 PIPPR Signature Library is created using PIPPR - Proteome Expression analysis Platform (powered by MS-SWATH). Go into the details of the proteome expression in your next CRISPR experiment.

Press Release

The partners have agreed to co-develop and market a portfolio of CRISPR QC products and services for quality control (QC) of CRISPR research, agricultural, and pre-clinical programs.

News

Development is moving fast in the genome editing field and new applications are launched every quarter but do we really understand the level of complexity in genome editing and how to address quality and safety?

Meet Us

It´s at the Precision Medicine World Conference, PMWC2020 and it´s all about QC Genome Editing, CRISPR InDel profiling and Proteomic analysis powered by SWATH Acquisition.

Article

Taking CRISPR Safety to the Next Level - "If we want to move to the clinic, we need to understand exactly what is going on inside the cells when we apply CRISPR "....

PIPPR Service

The HEK293 PIPPR Signature Library is created using PIPPR - Proteome Expression analysis Platform (powered by MS-SWATH). Go into the details of the proteome expression in your next CRISPR experiment.

News

The CRISPR Medicine Blog focus on topics related to gene therapy and genome editing using CRISPR (or other nucleases) for treatment of human diseases.

Meet Us

PIPPR - Fast, robust and cost-effective proteomic screening platform - powered by SWATH and developed for CRISPR applications.

Website News

Finally we can share with you the FAQ site for our CRISPR InDel Profiling Platform, CIPP - powered by IDAA.

NIST

The NIST Genome Editing Consortium seeks feedback on terms and definitions specific to genome editing.

Meet Us

SCIEX Seminar in Copenhagen, Denmark 3rd October 2019.

Product Launch

To support our Proteomic Expression analysis Platform, PIPPR, we are excited to launch the PIPPR Total Mammalian Protein Extraction kit

Press Release

We are excited to announce our new partnership with SCIEX for our proteomic expression analysis platform, PIPPR powered by SWATH LC-MS.

Product Launch

We are happy to share with you the launch of the powerful PROFILase 2x Master Mix - optimised for INDEL analysis using the IDAA method.

In the News

"Keep an eye on our Network Member, the Danish biotech company Cobo Technologies - potential to influence future drug development"

Collaboration Project

Great presentation by Roberto Nitsch, Safety Director, AstraZeneca at the NIST - Genome Editing Consortium Workshop 3rd May 2019 in US, on the idea behind their PIPPR project to understand the impact of CRISPR Base-Editors (ABE) on proteomic level.

Meeting

We are looking forward to meet all the members of the NIST - Genome Editing Consortium in US May 3rd. Our Co-founder and Scientific Advisor, Eric Paul Bennett and COO, Hasse Herlevsen will attend.

Corporate

To further strengthen our expertise within the Quality Control field, Hasse Herlevsen (former Corp. VP Quality, LEO Pharma) will join our team as COO.

Corporate

We are excited to announce that we have become member of the NIST - Genome Editing Consortium in US.

Corporate

Finally we can share with you all our new website - www.cobotechnologies.com.